• mail us help@24marketresearch.com
  • Int'l 1(332) 2424 294 (Int'l)

purchase customization

Leave This Empty:

choose chapter to purchase

table of content

Table of Contents
1 Research Methodology and Statistical Scope
1.1 Market Definition and Statistical Scope of Targeted Delivery Drugs
1.2 Key Market Segments
1.2.1 Targeted Delivery Drugs Segment by Type
1.2.2 Targeted Delivery Drugs Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 Targeted Delivery Drugs Market Overview
2.1 Global Market Overview
2.1.1 Global Targeted Delivery Drugs Market Size (M USD) Estimates and Forecasts (2019-2030)
2.1.2 Global Targeted Delivery Drugs Sales Estimates and Forecasts (2019-2030)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 Targeted Delivery Drugs Market Competitive Landscape
3.1 Global Targeted Delivery Drugs Sales by Manufacturers (2019-2024)
3.2 Global Targeted Delivery Drugs Revenue Market Share by Manufacturers (2019-2024)
3.3 Targeted Delivery Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Targeted Delivery Drugs Average Price by Manufacturers (2019-2024)
3.5 Manufacturers Targeted Delivery Drugs Sales Sites, Area Served, Product Type
3.6 Targeted Delivery Drugs Market Competitive Situation and Trends
3.6.1 Targeted Delivery Drugs Market Concentration Rate
3.6.2 Global 5 and 10 Largest Targeted Delivery Drugs Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 Targeted Delivery Drugs Industry Chain Analysis
4.1 Targeted Delivery Drugs Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 The Development and Dynamics of Targeted Delivery Drugs Market
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 Targeted Delivery Drugs Market Segmentation by Type
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Targeted Delivery Drugs Sales Market Share by Type (2019-2024)
6.3 Global Targeted Delivery Drugs Market Size Market Share by Type (2019-2024)
6.4 Global Targeted Delivery Drugs Price by Type (2019-2024)
7 Targeted Delivery Drugs Market Segmentation by Application
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Targeted Delivery Drugs Market Sales by Application (2019-2024)
7.3 Global Targeted Delivery Drugs Market Size (M USD) by Application (2019-2024)
7.4 Global Targeted Delivery Drugs Sales Growth Rate by Application (2019-2024)
8 Targeted Delivery Drugs Market Segmentation by Region
8.1 Global Targeted Delivery Drugs Sales by Region
8.1.1 Global Targeted Delivery Drugs Sales by Region
8.1.2 Global Targeted Delivery Drugs Sales Market Share by Region
8.2 North America
8.2.1 North America Targeted Delivery Drugs Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Targeted Delivery Drugs Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Targeted Delivery Drugs Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Targeted Delivery Drugs Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Targeted Delivery Drugs Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 Key Companies Profile
9.1 Adverum
9.1.1 Adverum Targeted Delivery Drugs Basic Information
9.1.2 Adverum Targeted Delivery Drugs Product Overview
9.1.3 Adverum Targeted Delivery Drugs Product Market Performance
9.1.4 Adverum Business Overview
9.1.5 Adverum Targeted Delivery Drugs SWOT Analysis
9.1.6 Adverum Recent Developments
9.2 Arrowhead Pharmaceuticals
9.2.1 Arrowhead Pharmaceuticals Targeted Delivery Drugs Basic Information
9.2.2 Arrowhead Pharmaceuticals Targeted Delivery Drugs Product Overview
9.2.3 Arrowhead Pharmaceuticals Targeted Delivery Drugs Product Market Performance
9.2.4 Arrowhead Pharmaceuticals Business Overview
9.2.5 Arrowhead Pharmaceuticals Targeted Delivery Drugs SWOT Analysis
9.2.6 Arrowhead Pharmaceuticals Recent Developments
9.3 Bayer
9.3.1 Bayer Targeted Delivery Drugs Basic Information
9.3.2 Bayer Targeted Delivery Drugs Product Overview
9.3.3 Bayer Targeted Delivery Drugs Product Market Performance
9.3.4 Bayer Targeted Delivery Drugs SWOT Analysis
9.3.5 Bayer Business Overview
9.3.6 Bayer Recent Developments
9.4 Windtree Therapeutics
9.4.1 Windtree Therapeutics Targeted Delivery Drugs Basic Information
9.4.2 Windtree Therapeutics Targeted Delivery Drugs Product Overview
9.4.3 Windtree Therapeutics Targeted Delivery Drugs Product Market Performance
9.4.4 Windtree Therapeutics Business Overview
9.4.5 Windtree Therapeutics Recent Developments
9.5 Immunocore
9.5.1 Immunocore Targeted Delivery Drugs Basic Information
9.5.2 Immunocore Targeted Delivery Drugs Product Overview
9.5.3 Immunocore Targeted Delivery Drugs Product Market Performance
9.5.4 Immunocore Business Overview
9.5.5 Immunocore Recent Developments
9.6 Mankind Pharma
9.6.1 Mankind Pharma Targeted Delivery Drugs Basic Information
9.6.2 Mankind Pharma Targeted Delivery Drugs Product Overview
9.6.3 Mankind Pharma Targeted Delivery Drugs Product Market Performance
9.6.4 Mankind Pharma Business Overview
9.6.5 Mankind Pharma Recent Developments
9.7 Roche
9.7.1 Roche Targeted Delivery Drugs Basic Information
9.7.2 Roche Targeted Delivery Drugs Product Overview
9.7.3 Roche Targeted Delivery Drugs Product Market Performance
9.7.4 Roche Business Overview
9.7.5 Roche Recent Developments
9.8 Ra Pharma
9.8.1 Ra Pharma Targeted Delivery Drugs Basic Information
9.8.2 Ra Pharma Targeted Delivery Drugs Product Overview
9.8.3 Ra Pharma Targeted Delivery Drugs Product Market Performance
9.8.4 Ra Pharma Business Overview
9.8.5 Ra Pharma Recent Developments
9.9 Keystone Nano
9.9.1 Keystone Nano Targeted Delivery Drugs Basic Information
9.9.2 Keystone Nano Targeted Delivery Drugs Product Overview
9.9.3 Keystone Nano Targeted Delivery Drugs Product Market Performance
9.9.4 Keystone Nano Business Overview
9.9.5 Keystone Nano Recent Developments
9.10 Lipocine
9.10.1 Lipocine Targeted Delivery Drugs Basic Information
9.10.2 Lipocine Targeted Delivery Drugs Product Overview
9.10.3 Lipocine Targeted Delivery Drugs Product Market Performance
9.10.4 Lipocine Business Overview
9.10.5 Lipocine Recent Developments
9.11 MultiVir
9.11.1 MultiVir Targeted Delivery Drugs Basic Information
9.11.2 MultiVir Targeted Delivery Drugs Product Overview
9.11.3 MultiVir Targeted Delivery Drugs Product Market Performance
9.11.4 MultiVir Business Overview
9.11.5 MultiVir Recent Developments
10 Targeted Delivery Drugs Market Forecast by Region
10.1 Global Targeted Delivery Drugs Market Size Forecast
10.2 Global Targeted Delivery Drugs Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Targeted Delivery Drugs Market Size Forecast by Country
10.2.3 Asia Pacific Targeted Delivery Drugs Market Size Forecast by Region
10.2.4 South America Targeted Delivery Drugs Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of Targeted Delivery Drugs by Country
11 Forecast Market by Type and by Application (2025-2030)
11.1 Global Targeted Delivery Drugs Market Forecast by Type (2025-2030)
11.1.1 Global Forecasted Sales of Targeted Delivery Drugs by Type (2025-2030)
11.1.2 Global Targeted Delivery Drugs Market Size Forecast by Type (2025-2030)
11.1.3 Global Forecasted Price of Targeted Delivery Drugs by Type (2025-2030)
11.2 Global Targeted Delivery Drugs Market Forecast by Application (2025-2030)
11.2.1 Global Targeted Delivery Drugs Sales (K Units) Forecast by Application
11.2.2 Global Targeted Delivery Drugs Market Size (M USD) Forecast by Application (2025-2030)
12 Conclusion and Key Findings